Skip to main content

Botanix up on study results

29/01/2018 - 15:20

Bookmark

Save articles for future reference.

Shares in medical dermatology company Botanix Pharmaceuticals, led by Perth-based chairman Graham Griffiths and executive director Matt Callahan, have jumped more than 20 per cent today after the company announced successful results from an acne patient study.

X

To read our articles you will need to either login or subscribe.